Puissance Cross-Border Opportunities II LLC 13D and 13G filings for Ekso Bionics Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2020-11-12 11:02 am Purchase |
2020-11-10 | 13D | Ekso Bionics Holdings, Inc. EKSO |
Puissance Cross-Border Opportunities II LLC | 39,786 0.480% |
39,786![]() (New Position) |
Filing |